Diagnostic value of cytokeratin 7, CD10 and mesothelin in distinguishing ovarian clear cell carcinoma from metastasis of renal clear cell carcinoma [13]

Histopathology

Volumn 51, Issue 6, 2007, Pages 874-876

  Leroy, X ^a   Farine, M O ^a   Buob, D ^a   Wacrenier, A ^a   Copin, M C ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; EOSIN; FORMALDEHYDE; HEMATOXYLIN; MESOTHELIN; PARAFFIN; TUMOR MARKER;

CELL ADHESION; CLEAR CELL CARCINOMA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LETTER; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; KIDNEY NEOPLASMS; MEMBRANE GLYCOPROTEINS; NEPRILYSIN; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 36549078096     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02874.x     Document Type: Letter

References (12)

1. Tavassoli FA, Devilee P. Tumours of the breast and female genital organs. World Health Organization Classification of Tumours. Lyon: IARC, 2003 117 145.
2. Valappil SV, Toon PG, Anandaram PS. Ovarian metastasis from primary renal cell carcinoma: report of a case and review of literature. Gynecol. Oncol. 2004 94 846 849.
3. Young RH, Hart WR. Renal cell carcinoma metastatic to ovary: a report of three cases emphasizing possible confusion with ovarian clear cell adenocarcinoma. Int. J. Gynecol. Pathol. 1992 11 96 104.
4. Hammock L, Ghorab Z, Carmen R et al. Metastatic renal cell carcinoma to the ovary. A case report and discussion of differential diagnoses. Arch. Pathol. Lab. Med. 2003 127 e123 e126.
5. Cameron RI, Ashe P, O'Rourke DM et al. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Int. J. Gynecol. Pathol. 2003 22 272 276.
6. Ohta Y, Suzuki T, Shiokawa A et al. Expression of CD10 and cytokeratins in ovarian and renal clear cell carcinoma. Int. J. Gynecol. Pathol. 2005 24 239 245.
7. Vang R, Whitaker BP, Farhood AI et al. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract. Int. J. Gynecol. Pathol. 2001 20 252 259.
8. Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am. J. Surg. Pathol. 2003 27 1418 1428.
9. Nolan LP, Heatley MK. The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary. Int. J. Gynecol. Pathol. 2001 20 155 159.
10. Hassan R, Bera T, Pastan I. Mesothelin: a new target for immunotherapy. Clin. Cancer Res. 2004 10 3937 3942.
11. Hassan R, Kreitman RJ, Pastan I et al. Localization of mesothelin in epithelial ovarian cancer. Appl. Immunohistochem. Mol. Morphol. 2005 13 243 247.
12. Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. Hum. Pathol. 2004 35 697 710.